Acorah Software Products - Accounts Production 16.0.110 false true 31 January 2023 1 February 2022 false true No description of principal activity 1 February 2023 31 January 2024 31 January 2024 12430476 S Clarke iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12430476 2023-01-31 12430476 2024-01-31 12430476 2023-02-01 2024-01-31 12430476 frs-core:CurrentFinancialInstruments 2024-01-31 12430476 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 12430476 frs-bus:FilletedAccounts 2023-02-01 2024-01-31 12430476 frs-bus:Micro-entities 2023-02-01 2024-01-31 12430476 frs-bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 12430476 frs-bus:Director1 2023-02-01 2024-01-31 12430476 2022-01-31 12430476 2023-01-31 12430476 2022-02-01 2023-01-31 12430476 frs-core:CurrentFinancialInstruments 2023-01-31
Registered number: 12430476
Revive Therapy Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2024
FOCUS ACCOUNTANTS LTD
Balance Sheet
Registered number: 12430476
2024 2023
£ £
Current assets 8,103 10,491
Creditors: Amounts Falling Due Within One Year (2,564 ) (9,599 )
NET CURRENT ASSETS 5,539 892
TOTAL ASSETS LESS CURRENT LIABILITIES 5,539 892
NET ASSETS 5,539 892
CAPITAL AND RESERVES 5,539 892

Notes

1. General Information
Revive Therapy Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12430476 . The registered office is 137-139 High Street, Beckenham, BR3 1AG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
S Clarke
Director
10/07/2024